Blocking the HIF ‐1α/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function
Allergy · 2025-05 · 80 (5) · 1309-1334
DOI: 10.1111/all.16361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 27.10.2024. Verfasst von Xiaogang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences); Department of Immunology, School of Ba…. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Glycolysis, Immunity, Innate, Lymphocytes. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: the Open Fund Project of Guangdong Academy of Medical Sciences, National Natural Science Foundation of China-Guangdong Joint Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The role of lung group 2 innate lymphoid cell (ILC2) activation in allergic asthma is increasingly established. However, the regulatory mechanisms underlying hypoxia‐inducible factor‐1α (HIF‐1α)‐mediated glycolysis in ILC2‐mediated allergic airway inflammation remain unclear.
Objective
To investigate the role of the HIF‐1α/glycolysis axis in ILC2‐mediated allergic airway inflammation.
Methods
Glycolysis and HIF‐1α inhibitors were used to identify their effect on the function and glucose metabolism of mouse and human ILC2s in vivo and vitro. Blocking glycolysis and HIF‐1α in mice under interleukin‐33 (IL‐33) stimulation were performed to test ILC2 responses. Conditional HIF‐1α‐deficient mice were used to confirm the specific role of HIF‐1α in ILC2‐driven airway inflammation models. Transcriptomic, metabolic, and chromatin immunoprecipitation analyses were performed to elucidate the underlying mechanism.
Results
HIF‐1α is involved in ILC2 metabolism and is crucial in allergic airway inflammation. Single‐cell sequencing data analysis and qPCR confirmation revealed a significant upregulation of glycolysis‐related genes, particularly HIF‐1α, in murine lung ILC2s after IL‐33 intranasal administration or injection. Treatment with the glycolysis inhibitor 2‐deoxy‐D‐glucose (2‐DG) and the HIF‐1α inhibitor 2‐methoxyestradiol (2‐ME) abrogated inflammation by suppressing ILC2s function. Conditional HIF‐1α‐deficient mice showed reduced ILC2 response and airway inflammation induced upon IL‐33 or house dust mite (HDM) stimulation. Transcriptome and metabolic analyses revealed significantly impaired glycolysis in lung ILC2s in conditional HIF‐1α knockout mice compared to that in their littermate controls. Chromatin immunoprecipitation results confirmed the transcriptional downregulation of glycolysis‐related genes in HIF‐1α‐knockout and 2‐DG‐treated mice. Furthermore, impaired HIF‐1α/glycolysis axis activation is correlated with downregulated ILC2 in patients with asthma.
Conclusion
The HIF‐1α/glycolysis axis is critical for controlling ILC2 responses in allergic airway inflammation and has potential immunotherapeutic value in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences); Department of Immunology, School of Basic Medical Sciences; Department of Clinical Laboratory, The Third Aff…
- Department of Clinical Laboratory, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
- Department of Immunology; Guangdong Provincial Key Laboratory of Single Cell Technology and Application, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
- Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University; Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Ho…
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China.
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
ORCID-Profile: Yumei He
Förderung
- the Open Fund Project of Guangdong Academy of Medical Sciences
- National Natural Science Foundation of China-Guangdong Joint Fund
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Liu, J., Li, X., Zheng, G., Wang, T., Sun, H., Huang, Z., He, J., Qiu, J., Zhao, Z., Guo, Y., & He, Y. (2025). Blocking the HIF ‐1α/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function. Allergy, 80(5), 1309-1334. https://doi.org/10.1111/all.16361
Vancouver
Zhang X, Liu J, Li X, Zheng G, Wang T, Sun H, et al. Blocking the HIF ‐1α/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function. Allergy. 2025;80(5):1309-1334. doi:10.1111/all.16361
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaogang and Liu, Jingping and Li, Xinyao and Zheng, Guilang and Wang, Tianci and Sun, Hengbiao and Huang, Zhengcong and He, Junyu and Qiu, Ju and Zhao, Zhibin and Guo, Yuxiong and He, Yumei},
title = {Blocking the HIF ‐1α/glycolysis axis inhibits allergic airway inflammation by reducing ILC2 metabolism and function},
journal = {Allergy},
year = {2025},
volume = {80},
number = {5},
pages = {1309--1334},
doi = {10.1111/all.16361}
}
EUVIMED